Clinical Medicine Insights-Oncology

Papers
(The H4-Index of Clinical Medicine Insights-Oncology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects55
The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors40
Radiation-Induced Fibrosis in Patients with Head and Neck Cancer: A Review of Pathogenesis and Clinical Outcomes25
Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer21
Radiomics in Nasopharyngeal Carcinoma19
Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer15
Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition14
Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges13
Emerging Roles for the Gut Microbiome in Lymphoid Neoplasms13
Immunotherapy-related gastritis: Two case reports and literature review11
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)11
1.4627811908722